Regulation of the Dynamic Proteome after Ischemic Injury
缺血性损伤后动态蛋白质组的调节
基本信息
- 批准号:10337192
- 负责人:
- 金额:$ 71.74万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-02-01 至 2024-01-31
- 项目状态:已结题
- 来源:
- 关键词:AcetylationAcuteAddressAffectAreaBiogenesisBioinformaticsBiological AssayCarbonCardiacCellsChromatinCoronary arteryDeacetylaseDevelopmentEpigenetic ProcessGene ExpressionGenetic TranscriptionGlycolysisHaplogroupHeartHeart failureHigh Fat DietInfarctionInterventionInvestigationIschemiaIsotopesLabelLeadLigationLinkMass Spectrum AnalysisMediatingMessenger RNAMetabolicMetabolic PathwayMetabolismMethyltransferaseMicroRNAsMicrofilamentsMitochondriaMitochondrial DNAMusMyocardial InfarctionMyocardiumNADHNatureNuclearOutputOxidative PhosphorylationPathway AnalysisPathway interactionsPhosphorylationPhosphotransferasesPhysiologyPioglitazonePolyribosomesPopulationPortraitsPost-Translational Protein ProcessingProcessProtein AcetylationProtein BiosynthesisProteinsProteomeProteomicsRNARecoveryRegulationReperfusion InjuryReperfusion TherapyResearchRiskRoleS-AdenosylmethionineSirtuinsStressTestingTissuesTranscriptional RegulationTranslationsUp-RegulationVariantWorkWorkloadanalogbasebioinformatics toolchromatin remodelingexperimental studyextracellulargenetic regulatory proteinheart functionhemodynamicshistone acetyltransferasein vivoischemic injurymetabolomemitochondrial dysfunctionmitochondrial metabolismmultiple omicsnovelnovel therapeuticspolysome profilingresponsetooltranscriptome
项目摘要
ABSTRACT
The premise of this work is based on the accumulated evidence that mitochondrial remodeling takes place in the
stressed heart after ischemic injury, and occurs not only in the area at risk, but also in the remaining viable
myocardium that must now alter its work capacity. We previously discovered that ischemia and reperfusion
resulted in mitophagy and biogenesis regulated at the level of RNA translation. This application will explore this
finding further by examining the dynamic protein composition of the active polysomes in hearts subjected to
ischemic stress. Aim 1 will test the hypothesis that regulatory molecules associate with polysomes during
ischemic stress and, in doing so, select mitochondria-targeted mRNAs for active translation. It will further
determine if miRNAs, or rather the loss of certain miRNAs, also govern this process. Results from this project
will develop a detailed portrait of the newly-synthesized proteins in the setting of recovery from ischemia, using
metabolic labeling with a mass spectrometry-compatible Met analog (azidohomoalanine, AHA) to define the new
protein proteome. Work in Aim 2 will define the relationship between alterations in mitochondrial function and
changes in the metabolome that alter protein acetylation and transcriptional output. Work in this aim will employ
various interventions to perturb glycolysis and oxidative phosphorylation, characterize the metabolome, and
correlate results with specific alterations in protein acetylation and the transcriptome, including both mRNA and
miRNA. Experiments will also be performed to explore perturbations, including a high-fat diet and variations in
mitochondrial haplogroup [using cybrid cells and the mitochondrial nuclear exchange (MNX) mouse lines]. The
multi-omics analysis will require the development of novel bioinformatics tools to identify relationships and control
nodes mediated through changes in metabolite levels. We have already identified a common pathway shared
by pioglitazone and GLP1Ra which increase the NADH/NAD+ ratio, inactivate sirtuins, result in increased protein
acetylation, and lower the expression and activity of miR-33. These studies will reveal the mechanisms governing
translational control of mitochondrial biogenesis, which may lead to the development of new therapeutic tools for
regulating this process in the setting of ischemia/reperfusion injury. The second and third aims will yield a new
understanding of the role that metabolism and mitochondrial output has on transcription, and is expected to
identify metabolites of particular importance in transcriptional regulation that may govern cardiac remodeling.
This project is focused on mechanisms of post-infarction remodeling and will yield a new understanding of the
link between mitochondrial function, metabolic output, and transcriptional regulation in the surviving myocardium
after infarction.
摘要
这项工作的前提是基于积累的证据,即线粒体重塑发生在细胞内。
缺血性损伤后的应激心脏,不仅发生在危险区域,而且还发生在剩余的存活区域。
心肌现在必须改变其工作能力。我们之前发现缺血和再灌注
导致在RNA翻译水平上调节线粒体自噬和生物发生。本应用程序将探讨这一点
通过检查心脏中活性多聚核糖体的动态蛋白质组成,
缺血性应激目的1将检验调节分子与多聚核糖体结合的假说,
缺血性应激,并在这样做时选择靶向mRNA进行主动翻译。将进一步
确定miRNAs,或者确切地说是某些miRNAs的丢失,是否也控制了这一过程。本项目的成果
将开发一个新的合成的蛋白质在缺血恢复设置的详细画像,使用
用质谱兼容的Met类似物(叠氮基高丙氨酸,AHA)进行代谢标记,以确定新的
蛋白质组目标2中的工作将定义线粒体功能改变与
改变蛋白质乙酰化和转录输出的代谢组学变化。为此目标的工作将雇用
干扰糖酵解和氧化磷酸化的各种干预,表征代谢组,
将结果与蛋白质乙酰化和转录组的特定改变相关联,包括mRNA和
小RNA。还将进行实验,以探索扰动,包括高脂肪饮食和变化,
线粒体单倍型群[使用胞质杂种细胞和线粒体核交换(MNX)小鼠系]。的
多组学分析将需要开发新的生物信息学工具,以确定关系和控制
节点通过代谢物水平的变化介导。我们已经确定了一条共同的道路,
通过吡格列酮和GLP 1 Ra增加NADH/NAD+比率,抑制sirtuins,导致蛋白质
乙酰化,并降低miR-33的表达和活性。这些研究将揭示
线粒体生物合成的翻译控制,这可能导致新的治疗工具的发展,
在缺血/再灌注损伤的情况下调节该过程。第二和第三个目标将产生一个新的
了解代谢和线粒体输出对转录的作用,预计
鉴定在转录调节中特别重要的代谢物,其可能支配心脏重塑。
该项目的重点是梗死后重塑的机制,并将产生一个新的理解,
存活心肌中线粒体功能、代谢输出和转录调控之间的联系
梗塞后。
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Proteomics of Mouse Heart Ventricles Reveals Mitochondria and Metabolism as Major Targets of a Post-Infarction Short-Acting GLP1Ra-Therapy.
- DOI:10.3390/ijms22168711
- 发表时间:2021-08-13
- 期刊:
- 影响因子:5.6
- 作者:de Freitas Germano J;Sharma A;Stastna M;Huang C;Aniag M;Aceves A;Van Eyk JE;Mentzer RM Jr;Piplani H;Andres AM;Gottlieb RA
- 通讯作者:Gottlieb RA
Asporin, an extracellular matrix protein, is a beneficial regulator of cardiac remodeling.
- DOI:10.1016/j.matbio.2022.04.005
- 发表时间:2022-06
- 期刊:
- 影响因子:6.9
- 作者:Huang, Chengqun;Sharma, Ankush;Thakur, Reetu;Rai, Deepika;Katiki, Madhusudhanarao;Germano, Juliana de Freitas;Song, Yang;Singh, Sakshi;Sin, Jon;Sengstock, David;Andres, Allen M.;Murali, Ramachandran;Mentzer, Robert M.;Gottlieb, Roberta A.;Piplani, Honit
- 通讯作者:Piplani, Honit
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Roberta A. Gottlieb其他文献
Erratum to: Hypercholesterolemia downregulates autophagy in the rat heart
勘误:关于:高胆固醇血症下调大鼠心脏中的自噬
- DOI:
10.1186/s12944-017-0524-4 - 发表时间:
2017-07-05 - 期刊:
- 影响因子:4.200
- 作者:
Zoltán Giricz;Gábor Koncsos;Tomáš Rajtík;Zoltán V. Varga;Tamás Baranyai;Csaba Csonka;Adrián Szobi;Adriana Adameová;Roberta A. Gottlieb;Péter Ferdinandy - 通讯作者:
Péter Ferdinandy
RETRACTED ARTICLE:Endocrine disruptors induce perturbations in endoplasmic reticulum and mitochondria of human pluripotent stem cell derivatives
撤回文章:内分泌干扰物诱导人类多能干细胞衍生物内质网和线粒体的扰动
- DOI:
10.1038/s41467-017-00254-8 - 发表时间:
2017-08-09 - 期刊:
- 影响因子:15.700
- 作者:
Uthra Rajamani;Andrew R. Gross;Camille Ocampo;Allen M. Andres;Roberta A. Gottlieb;Dhruv Sareen - 通讯作者:
Dhruv Sareen
Sex differences in ischemic heart disease and heart failure biomarkers
- DOI:
10.1186/s13293-018-0201-y - 发表时间:
2018-09-17 - 期刊:
- 影响因子:5.100
- 作者:
Kimia Sobhani;Diana K. Nieves Castro;Qin Fu;Roberta A. Gottlieb;Jennifer E. Van Eyk;C. Noel Bairey Merz - 通讯作者:
C. Noel Bairey Merz
Roberta A. Gottlieb的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Roberta A. Gottlieb', 18)}}的其他基金
Regulation of the Dynamic Proteome after Ischemic Injury
缺血性损伤后动态蛋白质组的调节
- 批准号:
10088465 - 财政年份:2019
- 资助金额:
$ 71.74万 - 项目类别:
Mitochondrial Quality in Cardioprotection: Overcoming Co-Morbidities
心脏保护中的线粒体质量:克服并发症
- 批准号:
8476844 - 财政年份:2013
- 资助金额:
$ 71.74万 - 项目类别:
Mitochondrial Quality in Cardioprotection: Overcoming Co-Morbidities
心脏保护中的线粒体质量:克服并发症
- 批准号:
9080647 - 财政年份:2013
- 资助金额:
$ 71.74万 - 项目类别:
Mitochondrial Quality in Cardioprotection: Overcoming Co-Morbidities
心脏保护中的线粒体质量:克服并发症
- 批准号:
8683224 - 财政年份:2013
- 资助金额:
$ 71.74万 - 项目类别:
Mitochondrial Quality in Cardioprotection: Overcoming Co-Morbidities
心脏保护中的线粒体质量:克服并发症
- 批准号:
9284595 - 财政年份:2013
- 资助金额:
$ 71.74万 - 项目类别:
In Vivo Imaging of Heart Disease and Host-Pathogen Processes
心脏病和宿主病原体过程的体内成像
- 批准号:
7796321 - 财政年份:2010
- 资助金额:
$ 71.74万 - 项目类别:
Rescue and Role of Complex I in myocardial ischemic injury
复合物I在心肌缺血损伤中的拯救及作用
- 批准号:
7822200 - 财政年份:2009
- 资助金额:
$ 71.74万 - 项目类别:
Subcellular Regulation of Autophagic Flux in Cardiomyocytes and the Heart
心肌细胞和心脏自噬流的亚细胞调节
- 批准号:
7847857 - 财政年份:2009
- 资助金额:
$ 71.74万 - 项目类别:
Subcellular Regulation of Autophagic Flux in Cardiomyocytes and the Heart
心肌细胞和心脏自噬流的亚细胞调节
- 批准号:
8223263 - 财政年份:2008
- 资助金额:
$ 71.74万 - 项目类别:
Juvenile mouse model of delayed anthracycline cardiotoxicity
迟发性蒽环类药物心脏毒性幼年小鼠模型
- 批准号:
8402845 - 财政年份:2008
- 资助金额:
$ 71.74万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 71.74万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 71.74万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 71.74万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 71.74万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 71.74万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 71.74万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 71.74万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 71.74万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 71.74万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 71.74万 - 项目类别:
Operating Grants














{{item.name}}会员




